Clinical trials
Phase 1/2 Carcinoma, Hepatocellular trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 2 |
| Amgen | 1 |
| Apollomics (Australia) Pty. Ltd. | 1 |
| Daiichi Sankyo | 1 |
| DualityBio Inc. | 1 |
| Forma Therapeutics, Inc. | 1 |
| Grey Wolf Therapeutics | 1 |
| Incyte Biosciences International Sàrl | 1 |
| Parabilis Medicines, Inc. | 1 |
| Western Sydney Local Health District | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 11 |
| Endometrial Neoplasms | 4 |
| Melanoma | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Uterine Cervical Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Colorectal Neoplasms | 3 |
| Carcinoma, Transitional Cell | 2 |
| Liver Neoplasms | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.